Scientists led by the Leibniz Research Center Borstel, the Institute of Microbiology and Laboratory Diagnostics in Gauting, the Institute of Medical Microbiology of the University of Zurich and the
In a current clinical trial, a team of scientists including researchers from the DZIF has shown that treating severe malaria in children can be simplified. The results have been published in PLOS
Researchers from the German Center for Infection Research (DZIF) and the University of Giessen have shown that the gene for resistance to colistin, which was recently discovered in China, also exists
For the first time, scientists from the Bernard Nocht Institute for Tropical Medicine (BNITM) including DZIF researchers have, in collaboration with Swiss colleagues, confirmed a long-lasting
A German-Dutch team of researchers has successfully vaccinated dromedaries against the MERScoronavirus. Dromedaries are believed to be the source of MERS infection in humans. At the German Center for
Tuberculosis is one of the most important infectious diseases worldwide. Treatment is lengthy and challenging. Doctors and scientists at the DZIF Clinical Center for Tuberculosis develop new therapies
His aim is to develop a vaccine against the widespread gastric pathogenHelicobacter pylori: for his work in this field, Professor Markus Gerhard, Technische Universität München (TUM), was awarded the
DZIF scientists at the University Hospital Cologne produce frozen gut flora preparations in capsules. The production protocol is freely accessible for interested colleagues.
The hepatitis A virus – like HIV or Ebola as well – is of likely animal origin. An international team of researchers under the lead of the University of Bonn uncovered the evolutionary origins of the
Researchers of the Paul Ehrlich Institute (PEI) together with groups at the DZIF have developed a vaccine against MERS, that is highly immunogenic and indicates protection of vaccinated mice in
